Ondansetron Stada

Ondondansetron, the active ingredient in Ondansetron Stada, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetron Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Ondansetron Stada is a selective 5‑HT3 receptor antagonist that is used across the nausea‑vomiting pathway of several clinical g  ....  . - Chemotherapy‑induced nausea and vomiting (CINV):    ...  . -    ....  ....  ...  .... ... "     …  

Common  

....

{"...":null}